Biocure Technology Inc (CURE.X.CX)
0.025
+0.02
(+150.00%)
CAD |
CNSX |
Sep 18, 10:40
Biocure Technology Enterprise Value: 0.9566M for Sept. 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2024 | 0.9566M |
| September 16, 2024 | 0.9566M |
| September 13, 2024 | 0.9566M |
| September 12, 2024 | 0.9566M |
| September 11, 2024 | 0.9566M |
| September 10, 2024 | 0.9566M |
| September 09, 2024 | 0.9566M |
| September 06, 2024 | 0.9566M |
| September 05, 2024 | 0.9566M |
| September 04, 2024 | 0.9566M |
| September 03, 2024 | 0.9566M |
| August 30, 2024 | 0.9566M |
| August 29, 2024 | 0.9566M |
| August 28, 2024 | 0.9566M |
| August 27, 2024 | 0.9566M |
| August 26, 2024 | 1.427M |
| August 23, 2024 | 1.427M |
| August 22, 2024 | 1.427M |
| August 21, 2024 | 1.427M |
| August 20, 2024 | 1.427M |
| August 19, 2024 | 1.427M |
| August 16, 2024 | 1.427M |
| August 15, 2024 | 1.427M |
| August 14, 2024 | 1.427M |
| August 13, 2024 | 1.427M |
| Date | Value |
|---|---|
| August 12, 2024 | 1.427M |
| August 09, 2024 | 1.427M |
| August 08, 2024 | 1.427M |
| August 07, 2024 | 1.427M |
| August 06, 2024 | 1.427M |
| August 02, 2024 | 1.427M |
| August 01, 2024 | 1.427M |
| July 31, 2024 | 1.427M |
| July 30, 2024 | 1.427M |
| July 29, 2024 | 1.427M |
| July 26, 2024 | 2.837M |
| July 25, 2024 | 2.837M |
| July 24, 2024 | 1.897M |
| July 23, 2024 | 0.4866M |
| July 22, 2024 | 0.4866M |
| July 19, 2024 | 0.4866M |
| July 18, 2024 | 0.4866M |
| July 17, 2024 | 0.4866M |
| July 16, 2024 | 0.4866M |
| July 15, 2024 | 0.4866M |
| July 12, 2024 | 0.4866M |
| July 11, 2024 | 0.4866M |
| July 10, 2024 | 0.9566M |
| July 09, 2024 | 0.9566M |
| July 08, 2024 | 0.9566M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.4866M
Minimum
Jul 11 2024
55.74M
Maximum
Jan 24 2020
14.05M
Average
12.90M
Median
Jan 27 2022
Enterprise Value Benchmarks
| Core One Labs Inc | 6.924M |
| Nova Mentis Life Science Corp | 0.7895M |
| Nanosphere Health Sciences Inc | 0.3707M |
| Lobe Sciences Ltd | 5.616M |
| Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0201M |
| Total Expenses (Quarterly) | 0.0633M |
| EPS Diluted (Quarterly) | -0.0002 |
| Earnings Yield | -167.6% |
| Normalized Earnings Yield | -237.55 |